Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.
Cho BS, Min CK, Kim HJ, Lee S, Kim YJ, Lim JY, Jeong DC, Cho B, Kim HK, Eom KS, Cho SG, Kim DW, Lee JW, Min WS, Kim CC, Chung NG. Cho BS, et al. Among authors: min ws, min ck. Biol Blood Marrow Transplant. 2010 May;16(5):629-38. doi: 10.1016/j.bbmt.2009.11.023. Epub 2009 Dec 4. Biol Blood Marrow Transplant. 2010. PMID: 19963070 Free article.
Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.
Lee S, Kim DW, Cho B, Kim YJ, Kim YL, Hwang JY, Park YH, Shin HJ, Park CY, Min WS, Kim HK, Kim CC. Lee S, et al. Among authors: min ws. Br J Haematol. 2003 Jan;120(1):145-53. doi: 10.1046/j.1365-2141.2003.03988.x. Br J Haematol. 2003. PMID: 12492591 Free article.
Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ, Kim DW, Lee S, Min CK, Goh HG, Kim SH, Lee JY, Kim YL, Kim HJ, Kim HJ, Lee JW, Kim TG, Min WS, Kim CC. Kim YJ, et al. Among authors: min ws, min ck. Biol Blood Marrow Transplant. 2004 Oct;10(10):718-25. doi: 10.1016/j.bbmt.2004.06.033. Biol Blood Marrow Transplant. 2004. PMID: 15389438 Free article. Clinical Trial.
The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW, Lee JW, Min WS, Kim CC. Lee S, et al. Among authors: min ws, min ck. Blood. 2005 May 1;105(9):3449-57. doi: 10.1182/blood-2004-09-3785. Epub 2005 Jan 18. Blood. 2005. PMID: 15657178 Free article. Clinical Trial.
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
Cho BS, Kim YJ, Cho SG, Kim SY, Eom KS, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Kim CC. Cho BS, et al. Among authors: min ws, min ck. Int J Hematol. 2007 Jun;85(5):446-55. doi: 10.1532/IJH97.A30616. Int J Hematol. 2007. PMID: 17562624 Clinical Trial.
253 results